$UVFT Kills More Than Just H1N1
February 19th, 2010 at 9:43 am Posted by The Dean
The last time The Dean’s 3rd Ivy League Stock Pick released news, $UVFT announced an exclusive agreement with Puravair LLC to distribute its patented, FDA approved UV400 Viraguard (Click HERE to view The Dean’s Special Report on $UVFT).
This announcement was issued about a month ago and The Dean’s curious about what could be in the works for this FDA approved Swine Flu Killer.
Some many feel that H1N1 (Influenza A) is no longer a threat and, therefore, $UVFT somehow loses market potential because it’s product only kills “Swine Flu” [Insert BUZZER sound] WRONG!
The Dean has taught all of his students that they must view $UVFT as not just a company whose product kills a potentially deadly, media-hyped virus but also a company with an FDA approved product that kills a long list of airborne bacteria and pathogens to improve indoor air quality overall.
$UVFT‘s UV400 Viraguard can be used in homes, schools, hospitals, doctors officers, malls, airports, movie theaters, restaurants, retail stores, churches, banquet halls—you name it.
The Dean believes that $UVFT‘s exclusive distribution agreement with Puravair could deliver in a major way because the company is said to have “many relationships in the Health Care and Hospitality industries,” which could mean “significant penetration into numerous vertical market segments in the Professional, Medical and Commercial sectors.”
Perhaps, $UVFT has big things in the works and their 2010 operations are not only up and running but also posting profits. But, for now, we don’t know any specifics.
What we do know, however, is between $UVFT‘s website and other sources of public information, The Dean believes there’s plenty of explosive potential for the CollegeStock Community and small cap world to be excited about.
